About the BNN (British Neurotoxin Network)
The British Neurotoxin Network (BNN) was founded on the 14th October 2011 to gather British clinicians who use Botulinum toxin (BoNT-A) injections for the treatment of focal dystonia, spasticity and other neurological disorders.
Available on this website are a series of Maps presenting both patients and doctors with the most appropriate medical centre for the treatment of each condition type.
I hope it will contribute to a better care for patients who require Botulinum toxin treatment throughout the United Kingdom.
Dr Marie-Helene Marion,
Founder of the BNN
The purpose of our organisation is:
- To promote communication between clinicians running BoNT-A clinics in the UK.
- To maintain up-to-date UK maps displaying the availability of BoNT-A services, in order to help clinicians and patients get the most appropriate care for a specific condition.
- To establish consensus regarding best practice throughout the UK, concerning doses, injection sites, the use of EMG or ultra-sound-guided injections and so forth.
- To improve BoNT-A services, namely through the promotion of local care via BoNT-A nurses and BoNT-A physiotherapists and in partnership with the Dystonia Society.
- To promote a multidisciplinary approach with our colleagues ENT, Maxillo-facial, rehabilitation, dermatologists and ophthalmologists.
We believe that, through these goals, the BNN will contribute to better care for patients requiring BoNT-A treatment and will act as a task force to work in partnership with the NHS, the pharmaceutical industry and patients support groups such as the Dystonia Society.